Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Receivables (2016 - 2025)

Dolby Laboratories' Receivables history spans 17 years, with the latest figure at $769.6 million for Q4 2025.

  • For Q4 2025, Receivables rose 4.68% year-over-year to $769.6 million; the TTM value through Dec 2025 reached $769.6 million, up 4.68%, while the annual FY2025 figure was $511.9 million, 25.46% down from the prior year.
  • Receivables reached $769.6 million in Q4 2025 per DLB's latest filing, up from $511.9 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $769.6 million in Q4 2025 to a low of $350.5 million in Q3 2022.
  • Average Receivables over 5 years is $571.4 million, with a median of $551.5 million recorded in 2023.
  • Peak YoY movement for Receivables: soared 146.35% in 2021, then tumbled 41.99% in 2022.
  • A 5-year view of Receivables shows it stood at $468.3 million in 2021, then soared by 56.49% to $732.8 million in 2022, then plummeted by 30.29% to $510.8 million in 2023, then skyrocketed by 43.93% to $735.2 million in 2024, then increased by 4.68% to $769.6 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Receivables are $769.6 million (Q4 2025), $511.9 million (Q3 2025), and $713.6 million (Q2 2025).